Assessing the efficacy‐effectiveness gap for cancer therapies: A comparison of overall survival and toxicity between clinical trial and population‐based, real‐world data for contemporary parenteral cancer therapeutics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Assessing the efficacy‐effectiveness gap for cancer therapies: A comparison of overall survival and toxicity between clinical trial and population‐based, real‐world data for contemporary parenteral cancer therapeutics

Published:2020-04-15 Issue:8 Volume:126 Page:1717-1726
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Phillips Cameron M.¹,Parmar Ambica¹²^ORCID,Guo Helen³,Schwartz Deborah³,Isaranuwatchai Wanrudee¹⁴,Beca Jaclyn³⁴,Dai Wei³⁴,Arias Jessica³,Gavura Scott³,Chan Kelvin K. W.¹²³⁴^ORCID

Affiliation:

1. Division of Medical Oncology and Hematology, Department of Medicine University of Toronto Toronto Ontario Canada

2. Odette Cancer Centre Sunnybrook Health Sciences Centre Toronto Ontario Canada

3. Cancer Care Ontario Toronto Ontario Canada

4. Canadian Centre for Applied Research in Cancer Control Toronto Ontario Canada

Funder

Canadian Centre for Applied Research in Cancer Control

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32697

Reference67 articles.

1. Efficacy and effectiveness trials have different goals, use different tools, and generate different messages

2. Pharmacoeconomic Evaluation in the Real World

3. Mind the gap: Efficacy versus effectiveness and pivotal prostate cancer clinical trial demographics

4. A Primer on Effectiveness and Efficacy Trials

5. Making trials matter: pragmatic and explanatory trials and the problem of applicability

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world uptake and effectiveness of triplet versus doublet chemotherapy with bevacizumab in patients with metastatic colorectal cancer in the United States;ESMO Gastrointestinal Oncology;2024-09

2. Why Should the FDA Focus on Pragmatic Clinical Research?;JAMA;2024-07-09

3. The efficacy and real-world effectiveness of a diet low in fermentable oligo-, di-, monosaccharides and polyols in irritable bowel syndrome: A systematic review and meta-analysis;Clinical Nutrition;2024-06

4. Efficacy-effectiveness analysis on survival in a population-based real-world study of BRAF-mutated metastatic colorectal cancer patients treated with encorafenib-cetuximab;British Journal of Cancer;2024-05-20

5. Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data;Cancer Immunology, Immunotherapy;2024-05-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3